These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36554293)

  • 21. Fatigue in multiple sclerosis patients with different clinical phenotypes: a clinical and magnetic resonance imaging study.
    Marchesi O; Vizzino C; Meani A; Conti L; Riccitelli GC; Preziosa P; Filippi M; Rocca MA
    Eur J Neurol; 2020 Dec; 27(12):2549-2560. PubMed ID: 32780554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theory of mind and its neuroanatomical correlates in people with multiple sclerosis.
    Yokote H; Okano K; Toru S
    Mult Scler Relat Disord; 2021 Oct; 55():103156. PubMed ID: 34332459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered social cognition in early relapsing remitting multiple sclerosis.
    Oliveira R; de Pinho GD; Silva D; Chester C; Marques IB
    Mult Scler Relat Disord; 2023 Oct; 78():104924. PubMed ID: 37566975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis.
    Jonkman LE; Rosenthal DM; Sormani MP; Miles L; Herbert J; Grossman RI; Inglese M
    PLoS One; 2015; 10(10):e0129380. PubMed ID: 26485710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.
    Triche EW; Ruiz JA; Olson KM; Lo AC
    Clin Neuropharmacol; 2016; 39(2):73-80. PubMed ID: 26818040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis.
    Joly H; Capet N; Mondot L; Cohen M; Suply C; Bresch S; Lebrun-Frenay C
    Mult Scler Relat Disord; 2020 Sep; 44():102374. PubMed ID: 32652509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatigue and its relation to general cognition, social cognition and social activity in multiple sclerosis and stroke.
    Lohaus T; Witt J; Schürmeyer A; Wolf OT; Thoma P
    Cogn Neuropsychiatry; 2023 May; 28(3):165-180. PubMed ID: 36782396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moral Cognition and Multiple Sclerosis: A Neuropsychological Study.
    Realmuto S; Dodich A; Meli R; Canessa N; Ragonese P; Salemi G; Cerami C
    Arch Clin Neuropsychol; 2019 May; 34(3):319-326. PubMed ID: 29850776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
    Hayter AL; Salkovskis PM; Silber E; Morris RG
    Br J Clin Psychol; 2016 Nov; 55(4):371-386. PubMed ID: 26806805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis.
    Goretti B; Portaccio E; Ghezzi A; Lori S; Moiola L; Falautano M; Viterbo R; Patti F; Vecchio R; Pozzilli C; Bianchi V; Cappiello S; Comi G; Trojano M; Amato MP;
    Mult Scler; 2012 Mar; 18(3):329-34. PubMed ID: 21844064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid foot-tapping but not hand-tapping ability is different between relapsing-remitting and progressive multiple sclerosis.
    Sato S; Lim J; Miehm JD; Buonaccorsi J; Rajala C; Khalighinejad F; Ionete C; Kent JA; van Emmerik REA
    Mult Scler Relat Disord; 2020 Jun; 41():102031. PubMed ID: 32172213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive multiple sclerosis and mood disorders.
    Lorefice L; Fenu G; Trincas G; Moro MF; Frau J; Coghe GC; Cocco E; Marrosu MG; Carta MG
    Neurol Sci; 2015 Sep; 36(9):1625-31. PubMed ID: 25899424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential patterns of memory performance in relapsing, remitting and secondary progressive multiple sclerosis.
    Drake MA; Carrá A; Allegri RF; Luetic G
    Neurol India; 2006 Dec; 54(4):370-6. PubMed ID: 17114845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Demographic and Clinical Factors in Cognitive Functioning of Persons with Relapsing-Remitting and Progressive Multiple Sclerosis.
    Costa SL; DeLuca J; Sandroff BM; Goverover Y; Chiaravalloti ND
    J Int Neuropsychol Soc; 2018 Feb; 24(2):139-146. PubMed ID: 28830576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in correlates of fatigue between relapsing and progressive forms of multiple sclerosis.
    Herring TE; Alschuler KN; Knowles LM; Phillips KM; Morean WM; Turner AP; Ehde DM
    Mult Scler Relat Disord; 2021 Sep; 54():103109. PubMed ID: 34237561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue.
    Betscher E; Guenter W; Langdon DW; Bonek R
    Neurol Neurochir Pol; 2021; 55(1):59-66. PubMed ID: 33047783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control.
    Cehelyk EK; Harvey DY; Grubb ML; Jalel R; El-Sibai MS; Markowitz CE; Berger JR; Hamilton RH; Chahin S
    Mult Scler Relat Disord; 2019 Jan; 27():269-275. PubMed ID: 30423531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological management of multiple sclerosis: evaluation of a supervised and customized cognitive rehabilitation program for self-used at home (SEPIA): protocol for a randomized controlled trial.
    Harand C; Daniel F; Mondou A; Chevanne D; Creveuil C; Defer G
    Trials; 2019 Oct; 20(1):614. PubMed ID: 31665039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clinical screening tool for objective and subjective cognitive disorders in multiple sclerosis.
    Guilloton L; Camdessanche JP; Latombe D; Neuschwander P; Cantalloube S; Thomas-Anterion C; Mercier B; Roggerone S; Maucort-Boulch D; Roche S; Jacquin-Courtois S;
    Ann Phys Rehabil Med; 2020 Mar; 63(2):116-122. PubMed ID: 30703524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.